#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type V Hereditary neuropathic amyloidosis Acute lymphocytic leukaemia Juvenile idiopathic arthritis Acute myeloid leukaemia (in remission) Ewing's sarcoma recurrent Severe myoclonic epilepsy of infancy Erdheim-Chester disease Osteomyelitis Immunodeficiency Congenital nephrogenic diabetes insipidus Albright's disease Hairy cell leukaemia recurrent Raynaud's phenomenon Extra-osseous Ewing's sarcoma More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Basic Information Lysosomal storage disorder – Basic Information Lysosomal storage disorder – Treatment Pelizaeus-Merzbacher disease – Treatment Leiomyosarcoma metastatic Glomerulonephritis rapidly progressive Epidermolysis bullosa – Diagnostics Leiomyosarcoma metastatic – Diagnostics Haemolytic uraemic syndrome – Treatment Adrenocortical carcinoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Montelukast Sodium Fluoride (18F) Basimglurant Pentixafor Macrogol 4000 Tamsulosin Hydrochloride BGB-16673 Elexacaftor Idursulfase Valiltramiprosate Bi 1819479 Isosorbide Dinitrate Itepekimab Clenbuterol Hydrochloride Levosimendan Ticagrelor Arginine Aluminium Hydroxide Taurine Resmetirom More therapies…

    Learn about Your Condition

    Axial spondyloarthritis Endometrial cancer stage III Blood iron increased Chronic fatigue syndrome Oesophageal atresia HIV infection Hyperplasia adrenal Polycystic liver disease Pancreatic failure Acute promyelocytic leukaemia Peritoneal dialysis Mitral valve disease Ovarian epithelial cancer Pouchitis Large cell lung cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • A study to evaluate the safety and effectiveness of nivolumab and imiquimod in adults with vulvar squamous cell carcinoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Imiquimod
    • Nivolumab
    France

  • Study evaluating the omission of exemestane, letrozole, anastrozole, and tamoxifen in postmenopausal women with low-risk early breast cancer.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • A study of irinotecan, fluorouracil, calcium folinate, zimberelimab, and domvanalimab for patients with metastatic gastro-enteropancreatic neuroendocrine carcinoma.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma metastatic
    Investigated Drugs:
    • Calcium Folinate
    • Domvanalimab
    • Fluorouracil
    France

  • Study of regorafenib as maintenance treatment after first-line therapy in patients with bone sarcomas without remaining disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Bone sarcoma
    Investigated Drugs:
    • Regorafenib
    France

  • Testing HPV Vaccine to Prevent Return of Precancerous Lesions in Patients Treated for High-Grade Abnormal Cell Changes Caused by HPV

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cervical dysplasia
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    France

  • Study of drug combination with radiotherapy versus radiotherapy alone for locally advanced rectal cancer in patients 75 years and older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Folinic Acid
    France

  • Study of M9140 for Patients With Advanced Pancreatic Cancer

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Austria France Germany Italy Spain

  • Study on the Effects of INT230-6, Vinblastine Sulfate, and Cisplatin in Patients with Early Triple-Negative Breast Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Cisplatin
    • Vinblastine Sulfate
    France

  • Study of Nivolumab and Ipilimumab or Drug Combination for Patients with Metastatic Kidney Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Study of Spartalizumab and Pazopanib for Patients with Refractory or Recurrent Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Pazopanib
    • Spartalizumab
    France
Previous Page
1 … 12 13 14 15 16 … 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!